Author:
Upfold Michele,Grobler Anneke,Suleman Fatima,Mansoor Leila E.
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference18 articles.
1. Woodsong C, MacQueen K, Amico KR, et al. Microbicide clinical trial adherence: insights for introduction. J Int AIDS Soc. 2013;16:18505.
2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–74.
3. Spilker B. Methods of assessing and improving patient compliance in clinical trials. IRB: Eth Hum Res. 1992;14(3):1–6.
4. FACTS 001 Phase III Trial of Pericoital Tenofovir 1% Gel for HIV Prevention in Women CROI 2015. Available from: http://www.croiconference.org/sessions/facts-001-phase-iii-trial-pericoital-tenofovir-1-gel-hiv-prevention-women .
5. Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.